Key facts
- This page summarizes Adam C. Vandervoort's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jun 2023, 16:12.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F2
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
Footnote F3
On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.